Revance Therapeutics, Inc. financial data

Location
Nashville, TN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 07 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 418% % -11%
Quick Ratio 75% % 84%
Debt-to-equity -458% % 82%
Return On Equity 136% % -92%
Return On Assets -38% % 48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104,902,388 shares 19%
Common Stock, Shares, Outstanding 104,895,611 shares 19%
Common Stock, Value, Issued $105,000 USD 19%
Weighted Average Number of Shares Outstanding, Basic 104,212,891 shares 20%
Weighted Average Number of Shares Outstanding, Diluted 104,212,891 shares 20%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $256,945,000 USD 26%
Research and Development Expense $77,240,000 USD 22%
Operating Income (Loss) $289,757,000 USD -1.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $36,615,000 USD 6.5%
Income Tax Expense (Benefit) $1,500,000 USD 400%
Net Income (Loss) Attributable to Parent $184,439,000 USD 55%
Earnings Per Share, Basic -2 USD/shares 61%
Earnings Per Share, Diluted -2 USD/shares 61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $58,585,000 USD -67%
Cash, Cash Equivalents, and Short-term Investments $184,100,000 USD -39%
Accounts Receivable, after Allowance for Credit Loss, Current $48,263,000 USD 90%
Inventory, Net $85,213,000 USD 84%
Assets, Current $329,687,000 USD -15%
Property, Plant and Equipment, Net $15,897,000 USD -7.5%
Operating Lease, Right-of-Use Asset $47,996,000 USD -12%
Intangible Assets, Net (Excluding Goodwill) $7,634,000 USD -27%
Other Assets, Noncurrent $172,000 USD -27%
Assets $461,564,000 USD -13%
Accounts Payable, Current $12,335,000 USD 158%
Employee-related Liabilities, Current $10,372,000 USD -60%
Accrued Liabilities, Current $34,022,000 USD -36%
Contract with Customer, Liability, Current $6,329,000 USD 18%
Liabilities, Current $80,049,000 USD -2.6%
Contract with Customer, Liability, Noncurrent $85,550,000 USD 1.5%
Operating Lease, Liability, Noncurrent $35,043,000 USD -17%
Other Liabilities, Noncurrent $2,911,000 USD 2.7%
Liabilities $624,594,000 USD -2.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $72,000 USD
Retained Earnings (Accumulated Deficit) $2,207,100,000 USD -9.1%
Stockholders' Equity Attributable to Parent $163,030,000 USD -54%
Liabilities and Equity $461,564,000 USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $65,939,000 USD 5.1%
Net Cash Provided by (Used in) Financing Activities $92,828,000 USD 2743%
Net Cash Provided by (Used in) Investing Activities $31,709,000 USD -133%
Common Stock, Shares Authorized 190,000,000 shares 0%
Common Stock, Shares, Issued 104,895,611 shares 19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,820,000 USD -117%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64,614,000 USD -65%
Operating Lease, Liability $41,415,000 USD -19%
Payments to Acquire Property, Plant, and Equipment $1,712,000 USD 97%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $184,354,000 USD 55%
Lessee, Operating Lease, Liability, to be Paid $56,941,000 USD -19%
Operating Lease, Liability, Current $6,372,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,185,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,854,000 USD 3.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15,526,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,536,000 USD -59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,021,000 USD -11%
Operating Lease, Payments $2,555,000 USD 23%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $6,130,000 USD -57%
Depreciation, Depletion and Amortization $1,981,000 USD -54%
Share-based Payment Arrangement, Expense $35,216,000 USD -20%
Interest Expense $20,115,000 USD 5.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%